Posted by Michael Wonder on 11 May 2021
Alberta faces shortage of COVID-19 drug as global demand spikes
11 May 2021 - Provinces with highest case rates hit by shortage of medication for sickest patients.
As Alberta's COVID-19 ICU admissions hit an all-time high, doctors are dealing with a shortage of one of just two drugs they can use to treat the sickest patients.
The pandemic has led to a spike in global demand for tocilizumab, an anti-inflammatory medication traditionally used to treat auto-immune conditions such as rheumatoid arthritis and side-effects related to some cancer treatments.
